Canada · Delayed Price · Currency is CAD Britannia Life Sciences Statistics
Total Valuation
CSE:BLAB has a market cap or net worth of CAD 10.55 million. The enterprise value is -6.36 million.
| Market Cap | 10.55M |
| Enterprise Value | -6.36M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:BLAB has 162.25 million shares outstanding.
| Current Share Class | 162.25M |
| Shares Outstanding | 162.25M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.38% |
| Owned by Institutions (%) | n/a |
| Float | 98.36M |
Valuation Ratios
The trailing PE ratio is 0.81.
| PE Ratio | 0.81 |
| Forward PE | n/a |
| PS Ratio | 22.21 |
| PB Ratio | 0.51 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.57, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.57 |
| Quick Ratio | 6.39 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.20 |
| Interest Coverage | -57.36 |
Financial Efficiency
Return on equity (ROE) is 96.67% and return on invested capital (ROIC) is -51.62%.
| Return on Equity (ROE) | 96.67% |
| Return on Assets (ROA) | -5.13% |
| Return on Invested Capital (ROIC) | -51.62% |
| Return on Capital Employed (ROCE) | -6.94% |
| Weighted Average Cost of Capital (WACC) | 4.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CSE:BLAB has paid 507,837 in taxes.
| Income Tax | 507,837 |
| Effective Tax Rate | 3.74% |
Stock Price Statistics
The stock price has decreased by -18.75% in the last 52 weeks. The beta is -0.07, so CSE:BLAB's price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | -18.75% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 38.96 |
| Average Volume (20 Days) | 229,771 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:BLAB had revenue of CAD 474,834 and earned 14.65 million in profits. Earnings per share was 0.09.
| Revenue | 474,834 |
| Gross Profit | 101,660 |
| Operating Income | -1.46M |
| Pretax Income | 13.58M |
| Net Income | 14.65M |
| EBITDA | -1.39M |
| EBIT | -1.46M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 17.14 million in cash and 229,141 in debt, with a net cash position of 16.91 million or 0.10 per share.
| Cash & Cash Equivalents | 17.14M |
| Total Debt | 229,141 |
| Net Cash | 16.91M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 20.75M |
| Book Value Per Share | 0.13 |
| Working Capital | 15.93M |
Cash Flow
| Operating Cash Flow | -1.16M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 62,798 |
| Net Borrowing | -110,774 |
| Free Cash Flow | -1.16M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 21.41%, with operating and profit margins of -306.82% and 3,085.51%.
| Gross Margin | 21.41% |
| Operating Margin | -306.82% |
| Pretax Margin | 2,860.35% |
| Profit Margin | 3,085.51% |
| EBITDA Margin | -293.59% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:BLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 138.92% |
| FCF Yield | -10.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 18, 2021. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 18, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
CSE:BLAB has an Altman Z-Score of 3.38 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.38 |
| Piotroski F-Score | 4 |